Literature DB >> 17994488

Gender differences in DUI offenders in treatment in Texas.

Jane Carlisle Maxwell1, James Freeman.   

Abstract

OBJECTIVE: This is a study of 8,464 adult women and 21,155 adult males who entered substance abuse treatment in Texas between 2000 and 2005. Participants were either on probation for driving under the influence (DUI), were referred to treatment by DUI probation, or had been arrested for DUI in the past year.
METHODS: The female and male clients were compared on demographic characteristics, substance use patterns, DSM-IV diagnoses, and levels of impairment. T tests and chi square tests were used to determine significance and multivariate logistic regression identified predictors of completing treatment and being abstinent at follow-up.
RESULTS: The proportion of females who were sent to treatment as a result of DUI increased from 27% in 2000 to 32% in 2005. Females were significantly more likely than males to be White (73% vs. 56%), to have used substances a shorter period of time (17 vs. 19 years), to be seeking custody to regain their children (11% vs. 2%), to meet the DSM criteria for drug dependence (32% vs. 23%), to have injected drugs (31% vs. 23%), to have used substances daily (42% vs. 40%), to have a depressive disorder (16% vs. 7%) or bipolar disorder (12% vs. 5%), and to be have been in treatment before (60% vs. 49%). In contrast, males were more likely to be alcohol dependent (49% vs. 44%). Females were less likely to complete treatment (67% vs. 72%) and reported significantly more days of problems on the 6 domains of the ASI at both admission and at 60-day follow-up. Furthermore, at follow-up, they were more likely to be living with someone who abused alcohol or used drugs (9% vs.7%).
CONCLUSIONS: Although females comprised only 29% of the DUI treatment admissions, they were more impaired and experienced more problems than their male counterparts. The findings indicate that additional resources, including treatment for co-occurring mental health problems and living in sober households, may be keys to helping these women achieve abstinence and prevent additional DUI episodes.

Entities:  

Mesh:

Year:  2007        PMID: 17994488     DOI: 10.1080/15389580701586810

Source DB:  PubMed          Journal:  Traffic Inj Prev        ISSN: 1538-9588            Impact factor:   1.491


  6 in total

1.  Personality traits and mental health of severe drunk drivers in Sweden.

Authors:  Beata Hubicka; Håkan Källmén; Arto Hiltunen; Hans Bergman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07       Impact factor: 4.328

2.  Brief Report: Sex Differences in Substance Use, Mental Health, and Impaired Driving Among Rural DUI Offenders.

Authors:  J Matthew Webster; Michele Staton; Megan F Dickson
Journal:  Am J Addict       Date:  2019-05-21

3.  Impaired driving among rural female drug-involved offenders.

Authors:  J Matthew Webster; Martha Tillson; Megan F Dickson; Michele Staton
Journal:  Traffic Inj Prev       Date:  2020-09-17       Impact factor: 1.491

4.  Elevated maternal and child mortality among women with multiple DUI convictions compared with socio-demographically matched controls.

Authors:  Vivia V McCutcheon; Kathleen K Bucholz; Alexandra N Houston-Ludlam; Andrew C Heath
Journal:  Addiction       Date:  2019-08-22       Impact factor: 6.526

5.  Alcohol criteria endorsement and psychiatric and drug use disorders among DUI offenders: greater severity among women and multiple offenders.

Authors:  Vivia V McCutcheon; Andrew C Heath; Howard J Edenberg; Richard A Grucza; Victor M Hesselbrock; John R Kramer; Laura Jean Bierut; Kathleen K Bucholz
Journal:  Addict Behav       Date:  2008-12-24       Impact factor: 3.913

6.  The effect of lowering the legal blood alcohol concentration limit on driving under the influence (DUI) in southern Taiwan: a cross-sectional retrospective analysis.

Authors:  Yu-Chin Tsai; Shao-Chun Wu; Jin-Fu Huang; Spencer C H Kuo; Cheng-Shyuan Rau; Peng-Chen Chien; Hsiao-Yun Hsieh; Ching-Hua Hsieh
Journal:  BMJ Open       Date:  2019-04-20       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.